Latest Hematology & Oncology News
QOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma
posted November 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
posted November 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes
posted November 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Oncogenic Variants Identified in ~10 Percent With Appendix Cancer
posted November 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Gene Mutation Identified That Increases Lung Cancer Risk 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Relapse Rare After Appendiceal Adenocarcinoma Resection Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 Hematology & Oncology Conference Highlights
Hematology & Oncology Monthly Briefings
Hematology & Oncology Conference News
Stay Connected
